<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02966405</url>
  </required_header>
  <id_info>
    <org_study_id>PekingUIH</org_study_id>
    <nct_id>NCT02966405</nct_id>
  </id_info>
  <brief_title>The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women</brief_title>
  <official_title>The Establish of Trimester-specific Reference Ranges for Thyroid Tests in Pregnant Women and the Influence of Thyroid Disorders on Pregnancy and Its Outcomes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiaomei Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University International Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A descriptive analysis involving 300 healthy pregnant women to the establish of
      trimester-specific reference ranges for thyroid tests in pregnant women. 700 cases were
      selected as the normal pregnant population to establish a self-sequential longitudinal
      reference range.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A descriptive analysis involving 300 healthy pregnant women according NACB to the establish
      of trimester-specific reference ranges for thyroid tests in pregnant women. According to the
      selection criteria, 700 cases were selected as the normal pregnant population to establish a
      self-sequential longitudinal reference range. The aim of this study to monitor the change of
      thyroid function and antibody during the course of pregnancy in those who suffer from various
      thyroid disorders and normal control.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Detection the FT3,FT4,TSH,TPOAb of the pregnant women in trimester of pregnancy.</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Detection the FT3,FT4,TSH,TPOAb of the pregnant women in trimester of pregnancy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The influence of thyroid disorders on pregnancy.</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Pregnant women:subclinical hypothyroidism,hypertension of pregnancy, eclampsia gravidarum, gestational diabetes mellitus, abortion, stillbirth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The influence of thyroid disorders its outcomes.</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Newborn:neonatal death,neonatal respiratory distress syndrome, low birth weight, macrosomia,et al.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Diseases Pregnancy Thyroid</condition>
  <arm_group>
    <arm_group_label>Healthy pregnant women</arm_group_label>
    <description>A descriptive analysis involving 300 healthy pregnant women according NACB to the establish of trimester-specific reference ranges for thyroid tests in pregnant women.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal pregnant population</arm_group_label>
    <description>According to the selection criteria, 700 cases were selected as the normal pregnant population to establish a self-sequential longitudinal reference range. The aim of this study to monitor the change of thyroid function and antibody during the course of pregnancy in those who suffer from various thyroid disorders and normal control.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A descriptive analysis involving 300 healthy pregnant women according NACB to the establish
        of trimester-specific reference ranges for thyroid tests in pregnant women. According to
        the selection criteria, 700 cases were selected as the normal pregnant population to
        establish a self-sequential longitudinal reference range. The aim of this study to monitor
        the change of thyroid function and antibody during the course of pregnancy in those who
        suffer from various thyroid disorders and normal control.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The people who lived in the city more than five years, aged between 19 and 45, or the
             single pregnancy women who registered or checked in Peking University international
             hospital would be enrolled.

          2. The pregnancy confirmed by the ultrasound or blood HCG test.

          3. In order to build a pregnancy reference range of normal pregnant women who must meet
             the NACB standard.

        Exclusion Criteria:

          1. The history of thyroid disorders.

          2. Goiter.

          3. Oral contraceptives or any drugs affected the function of thyroid.

          4. With other chronic autoimmune disease, malignant tumor, blood disease, etc

          5. Twin pregnancies and multiple pregnancies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiao M zhang, Chief</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University International Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiao M zhang, Chief</last_name>
    <phone>010 69006260</phone>
    <email>yuanning00076@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University International Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>102206</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaomei Zhang, Director</last_name>
      <phone>6900 6260</phone>
      <email>yuanning00076@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Ning Yuan</last_name>
      <phone>010 6900 6260</phone>
      <email>yuanning@pkuih.edu.cn</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Peking University International Hospital</name>
      <address>
        <city>Changping</city>
        <state>Beijing</state>
        <zip>102206</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaomei Zhang, Director</last_name>
      <phone>6900 6294</phone>
      <email>yuanning00076@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2016</study_first_submitted>
  <study_first_submitted_qc>November 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2016</study_first_posted>
  <last_update_submitted>November 21, 2016</last_update_submitted>
  <last_update_submitted_qc>November 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking University International Hospital</investigator_affiliation>
    <investigator_full_name>Xiaomei Zhang</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

